NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies cash
Cash and short-term investments held at the end of each period.
Neuroone Medical Technologies's cash was $2.05M at Jun 30, 2026. For fiscal 2025 it was $6.57M, up 350.0% from the year before. Over ten years it grew 156.9% a year on average. The highest annual figure on record is $11.14M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $6.57M | +350.0% |
| FY2024 | Sep 30, 2024 | $1.46M | -72.6% |
| FY2023 | Sep 30, 2023 | $5.32M | -52.2% |
| FY2022 | Sep 30, 2022 | $11.14M | +61.4% |
| FY2021 | Sep 30, 2021 | $6.90M | +71.0% |
| FY2020 | Sep 30, 2020 | $4.04M | +15150.7% |
| FY2017 | Dec 31, 2017 | $26.47K | -94.9% |
| FY2016 | Dec 31, 2016 | $522.22K | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $205 | -61.0% |
| FY2013 | Dec 31, 2013 | $525 | -53.0% |
| FY2012 | Dec 31, 2012 | $1.12K | -91.9% |
| FY2011 | Dec 31, 2011 | $13.85K | +51.7% |
| FY2010 | Dec 31, 2010 | $9.13K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $2.05M | -74.5% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $2.80M | +112.4% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $3.56M | +214.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $6.57M | +350.0% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $8.04M | +396.3% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $1.32M | -45.8% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $1.13M | -57.7% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $1.46M | -72.6% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $1.62M | -47.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $2.43M | -47.0% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $2.68M | -64.9% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $5.32M | -52.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $3.08M | -69.7% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $4.60M | -64.3% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $7.64M | -52.8% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $11.14M | +61.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $10.18M | +13.2% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $12.87M | +14.1% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $16.18M | +127.0% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $6.90M | +71.0% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $8.99M | +135.1% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $11.27M | +1408.8% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $7.13M | +248.7% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.04M | +15150.7% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $3.82M | +5360.5% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $747.24K | +53.6% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $2.04M | +320.3% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $26.47K | -94.9% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $70.03K | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $486.42K | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $486.42K | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $522.22K | – |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | $0 | – |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | $0 | – |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | $0 | -100.0% |
| Q4 FY2015CQ4 2015 | Dec 31, 2015 | $0 | -100.0% |
| Q3 FY2015CQ3 2015 | Sep 30, 2015 | $0 | – |
| Q2 FY2015CQ2 2015 | Jun 30, 2015 | $0 | – |
| Q1 FY2015CQ1 2015 | Mar 31, 2015 | $195 | – |
| Q4 FY2014CQ4 2014 | Dec 31, 2014 | $205 | – |
See a number that looks wrong?